BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 8629262)

  • 1. [Low-grade malignant non-Hodgkin lymphomas--current status and trends in therapy].
    Hiddemann W
    Ther Umsch; 1996 Feb; 53(2):123-32. PubMed ID: 8629262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Therapy of low-grade non-Hodgkin lymphomas].
    Hiddemann W; Unterhalt M; Wörmann B
    Praxis (Bern 1994); 1996 Mar; 85(12):357-63. PubMed ID: 8643898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current status and future perspectives in the treatment of low-grade non-Hodgkin's lymphomas.
    Hiddemann W; Unterhalt M
    Blood Rev; 1994 Dec; 8(4):225-33. PubMed ID: 7888829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapy of low-grade non-Hodgkin's lymphoma].
    Heinz R; Hopfinger-Limberger G
    Wien Klin Wochenschr; 1994; 106(10):321-6. PubMed ID: 8053200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low grade malignant non-Hodgkin's lymphomas and peripheral pleomorphic T-cell lymphomas in childhood--a BFM study group report.
    Bucsky P; Feller AC; Reiter A; Beck J; Bertram U; Eschenbach C; Gerein V; Lakomek M; Stollmann B; Tausch W
    Klin Padiatr; 1990; 202(4):258-61. PubMed ID: 2203939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of follicular follicle centre lymphomas: current status and future perspectives.
    Hiddemann W; Unterhalt M; Buske C; Sack H
    J Intern Med Suppl; 1997; 740():55-62. PubMed ID: 9350184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [R.E.A.L. classification of non-Hodgkin lymphoma from the clinico-oncologic viewpoint].
    Meusers P; Brittinger G
    Praxis (Bern 1994); 1998 Jun; 87(23):793-800. PubMed ID: 9654985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current treatment of follicular and low-grade non-Hodgkin's lymphoma.
    Linch D
    Anticancer Drugs; 2001 Jun; 12 Suppl 2():S5-9. PubMed ID: 11508934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Recent progress in the treatment of malignant lymphoma].
    Ogura M
    Gan To Kagaku Ryoho; 2001 Sep; 28(9):1213-35. PubMed ID: 11579632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment outcome and prognostic factors for relapse after high-dose chemotherapy and peripheral blood stem cell rescue for patients with poor risk high grade non-Hodgkin's lymphoma.
    Lee SM; Ryder WD; Clemons MJ; Morgenstern GR; Chang J; Scarffe JH; Radford JA
    Bone Marrow Transplant; 1999 Aug; 24(3):271-7. PubMed ID: 10455365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase II multicenter trial of high-dose sequential chemotherapy and peripheral blood stem cell transplantation as initial therapy for patients with high-risk non-Hodgkin's lymphoma.
    Schenkein DP; Roitman D; Miller KB; Morelli J; Stadtmauer E; Pecora AL; Cassileth P; Fernandez H; Cooper BW; Kutteh L; Lazarus HM
    Biol Blood Marrow Transplant; 1997 Oct; 3(4):210-6. PubMed ID: 9360783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-Hodgkin's lymphomas--current status of therapy and future perspectives.
    Hiddemann W
    Eur J Cancer; 1995 Dec; 31A(13-14):2141-5. PubMed ID: 8652232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High rates of long-lasting remissions after 5-day bendamustine chemotherapy cycles in pre-treated low-grade non-Hodgkin's-lymphomas.
    Bremer K
    J Cancer Res Clin Oncol; 2002 Nov; 128(11):603-9. PubMed ID: 12458340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and subclassification of follicle center and mantle cell lymphomas on fine-needle aspirates: A cytologic and immunocytochemical approach based on the Revised European-American Lymphoma (REAL) classification.
    Rassidakis GZ; Tani E; Svedmyr E; Porwit A; Skoog L
    Cancer; 1999 Aug; 87(4):216-23. PubMed ID: 10455210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical and prognosis relevance of the Kiel classification of non-Hodgkin lymphomas].
    Brittinger G; Engelhard M
    Verh Dtsch Ges Pathol; 1992; 76():37-46. PubMed ID: 1283273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diffuse aggressive lymphomas: a curable subset of non-Hodgkin's lymphomas.
    Skarin AT
    Semin Oncol; 1986 Dec; 13(4 Suppl 5):10-25. PubMed ID: 2432666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapeutic advances for indolent lymphomas].
    Ogura M
    Nihon Rinsho; 2000 Mar; 58(3):682-94. PubMed ID: 10741147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Sequential polychemotherapy and large-field radiotherapy of non-Hodgkin's lymphoma].
    Kuse R; Heilmann HP; Calavrezos A; Hausmann K
    Strahlentherapie; 1985 Apr; 161(4):231-8. PubMed ID: 3922093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon alfa for the treatment of follicular lymphomas.
    Hiddemann W; Griesinger F; Unterhalt M
    Cancer J Sci Am; 1998 Jul; 4 Suppl 2():S13-8. PubMed ID: 9672770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.